HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dynamic changes in insulin requirements with post-operative time using bedside artificial pancreas to maintain normoglycemia without hypoglycemia after cardiac surgery.

Abstract
It is difficult to manage postoperative blood glucose levels without hyperglycemia and hypoglycemia in cardiac surgery patients even if continuous intravenous insulin infusion is used. Therefore, the insulin requirements for maintaining normoglycemia may be difficult to evaluate and need to be elucidated. In this single-center retrospective study, 30 adult patients (age 71.5 ± 9.0 years old, men 67%, BMI 22.0 ± 3.1 kg/m2, diabetes 33%) who underwent cardiac surgery and used bedside artificial pancreas (STG-55) as a perioperative glycemic control were included. We investigated the insulin and glucose requirements to maintain normoglycemia until the day after surgery. The bedside artificial pancreas achieved intensive glycemic control without hypoglycemia under fasting conditions for 15 h after surgery (mean blood glucose level was 103.3 ± 3.1 mg/dL and percentage of time in range (70-140 mg/dL) was 99.4 ± 2.0%). The total insulin requirement for maintaining normoglycemia differed among surgical procedures, including the use of cardiopulmonary bypass during surgery, while it was not affected by age, body mass index, or the capacity of insulin secretion. Moreover, the mean insulin requirement and the standard deviation of the insulin requirements were variable and high, especially during the first several hours after surgery. Treatment using the bedside artificial pancreas enabled intensive postoperative glycemic control without hypoglycemia. Furthermore, the insulin requirements for maintaining normoglycemia after cardiac surgery vary based on surgical strategies and change dynamically with postoperative time, even in the short term.
AuthorsShin Urai, Naoko Hashimoto, Michinori Takabe, Motoharu Kawashima, Yuka Satake, Yuki Nishimoto, Mitsuo Kuroda, Yu Yamane, Kazuki Doi, Tetsuya Oue, Hirohisa Murakami, Nobuhiko Mukohara, Takeshi Ohara
JournalJournal of artificial organs : the official journal of the Japanese Society for Artificial Organs (J Artif Organs) Vol. 25 Issue 1 Pg. 72-81 (Mar 2022) ISSN: 1619-0904 [Electronic] Japan
PMID34191199 (Publication Type: Journal Article)
Copyright© 2021. The Japanese Society for Artificial Organs.
Chemical References
  • Blood Glucose
  • Hypoglycemic Agents
  • Insulin
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Blood Glucose
  • Cardiac Surgical Procedures (adverse effects)
  • Humans
  • Hypoglycemia (etiology, prevention & control)
  • Hypoglycemic Agents
  • Insulin
  • Male
  • Middle Aged
  • Operative Time
  • Pancreas, Artificial
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: